This compound is a spirocyclic pharmaceutical intermediate featuring a hydroxy group, a methylsulfanyl substituent, and a tert-butyl ester protecting group. Its structure contains multiple aromatic and heterocyclic rings, and it is primarily used in the synthesis of kinase inhibitors for research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2170746-97-9
Tert-butyl 4-methylsulfanyl-10-oxo-8-(trifluoromethylsulfonyloxy)spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
research intermediate
5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde
pharmaceutical intermediate
3-Amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
pharmaceutical intermediate
2-(1-(Ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
pharmaceutical intermediate
2-Bromo-5-(4-methylbenzene-1-sulfonyl)-5H-pyrrolo[2,3-b]pyrazine
pharmaceutical intermediate
Trilaciclib Impurity 3
pharmaceutical intermediate
Benzyl (2S)-2-{8-aminoimidazo[1,5-a]pyrazin-3-yl}pyrrolidine-1-carboxylate
pharmaceutical intermediate
Fmoc-Ile-Aib-OH
pharmaceutical intermediate
tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
WISYVWISRLRKNF-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CC2(CCCCC2)N3C(=C(C4=CN=C(N=C43)SC)O)C1=O
—